A R T I C L E S
Hong et al.
1.26 (m, 1H), 1.04 (br s, 1H); 13C NMR (125.7 MHz, C6D6) δ 135.9,
124.7, 61.5, 47.1, 33.2, 26.0, 18.2. MS (rel abundance): M+ 111.1
(14), 110.1 (22), 96.1 (73), 83.1 (11), 82.1 (13), 70.1 (38), 68.1 (100),
67.1 (12), 41.1 (25), 39.1 (18). HRMS-EI (m/z): [M+] calcd for C7H13N,
111.1048; found, 111.1047.
2-[(Z)-Prop-1-enyl]pyrrolidine (2b).11b 13C NMR (125.7 MHz,
C6D6) δ 135.7, 124.5, 56.0, 47.3, 33.4, 26.3, 13.7. MS (rel abun-
dance): M+ 111.1 (14), 110.1 (22), 96.1 (73), 83.1 (11), 82.1 (13),
70.1 (38), 68.1 (100), 67.1 (12), 41.1 (25), 39.1 (18).
Hz, 3H), 1.78-1.49 (m, 5H), 1.48-1.34 (m, 1H); 13C NMR (125.7
MHz, CDCl3) δ 155.9, 137.3, 129.2, 128.6, 128.0, 127.9, 127.1, 67.1,
52.4, 40.2, 29.6, 25.8, 19.6, 18.1. IR (neat) 3063, 3030, 2937, 2857,
1703, 1497, 1445, 1421, 1351, 1355, 1323, 1257. MS (rel abundance):
M+ 259.2 (1), 168.1 (37), 124.1 (20), 92.1 (8), 91.1 (100), 82.1 (9),
65.1 (15), 55.1 (10). HRMS-EI (m/z): [M+] calcd for C16H21NO2,
259.1572; found, 259.1572. Anal. Calcd for C16H21NO2: C, 74.10; H,
8.16; N, 5.40. Found: C, 73.88; H, 8.23; N, 5.34.
1
3,3-Dimethyl-6-[(E)-prop-1-enyl]piperidine (8a). H NMR (500
2-(Prop-2-enyl)pyrrolidine (2c). 13C NMR (125.7 MHz, C6D6) δ
137.5, 116.3, 59.0, 41.7, 31.8, 26.2, 26.0. MS (rel abundance): [M -
41]+ 70.1 (100), 68.1 (11), 43.1 (10), 41.1 (12).
MHz, CDCl3) δ 5.57 (dq, 15.5 Hz, 6 Hz, 1H), 5.46 (dd, 15.5 Hz, 6 Hz,
1H), 2.92-2.89 (m, 1H), 2.59 (dd, 12 Hz, 2 Hz, 1H), 2.46 (d, 12 Hz,
1H), 1.65 (d, 6 Hz, 3H), 1.48-1.22 (m, 4H), 0.97 (s, 3H), 0.83 (s,
3H); 13C NMR (125.7 MHz, CDCl3) δ 135.0, 124.9, 59.0, 58.7, 37.9,
29.8, 29.4, 23.9, 18.1. MS (rel abundance): M+ 153 (31), 138 (97),
125 (25), 110 (58), 96 (30), 82 (51), 70 (77), 68 (100), 67 (38), 55
(29), 41 (51). HRMS-EI (m/z): [M+] calcd for C10H19N, 153.1518;
found, 153.1523.
N-Boc-2-[(E)-but-1-enyl]pyrrolidine (Boc-10a). 1H NMR (400
MHz, CDCl3): δ 5.49 (br s, 1H), 5.32 (br s, 1H), 4.32 and 4.17 (br s,
1H), 3.38 (br s, 2H), 2.07-1.92 (m, 1H), 2.03 (quintet, 7 Hz, 2H),
1.90-1.73 (m, 2H), 1.70-1.64 (m, 1H), 1.44 (s, 9H), 0.98 (t, 7 Hz,
3H); 13C NMR (125.7 MHz, CDCl3): δ 155.4, 132.2, 129.8, 79.1, 58.9,
46.4, 32.8, 28.7, 25.4, 23.2, 14.0. MS (rel abundance): M+ 225.2 (1),
169.1 (17), 152.1 (17), 140.1 (100), 114.1 (57), 108.1 (9), 96.1 (30),
70.1 (14), 68.1 (11), 67.1 (14), 57.1 (78), 55.1 (11), 43.0 (9), 41.0
(45), 39.0 (16). HRMS-EI (m/z): [M+] calcd for C13H23NO2, 225.1729;
found, 225.1727.
N-Boc-2-[prop-1-enyl]pyrrolidine (Boc-2a/b).21 1H NMR (500
MHz, CDCl3) δ 5.48 (br s, 1H), 5.35 (br s, 1H), 4.53 (br s, 0.4H), 4.29
and 4.17 (br s, 0.6H), 3.38 (br s, 2H), 2.10-1.75 (m, 3H), 1.70 (d, 6.0
Hz, 3H), 1.64-1.58 (m, 1H), 1.44 (s, 9H). Both isomers exhibit
indistinguishable mass spectra; MS (rel abundance): M+ 211.2 (1),
155.1 (56), 140.1 (100), 138.1 (20), 114.1 (15), 110.1 (13), 96.1 (38),
83.1 (10), 70.1 (15), 68.1 (22), 67.1 (15), 57.1 (100), 56.1 (10), 55.1
(14), 43.0 (13), 42.0 (11), 41.1 (66), 39.0 (28). HRMS-EI (m/z): [M+]
calcd for C12H21NO2, 211.1572; found, 211.1571.
N-Boc-2-(prop-2-enyl)pyrrolidine (Boc-2c).21 1H NMR (500 MHz,
CDCl3) δ 5.75 (m, 1H), 5.06 (d, 16.5 Hz, 1 H), 5.03 (d, 8.5 Hz, 1H),
3.87 and 3.77 (br s, 1H), 3.40 and 3.32 (br s, 2H), 2.55 and 2.43 (br s,
1H), 2.14 and 2.11 (t, 8.0 Hz, 1H), 1.94-1.69 (m, 4H), 1.47 (s, 9H).
MS (rel abundance): [M - 41]+ 170.1 (9), 114.1 (65), 70.1 (100),
57.1 (84), 41.1 (40), 39.1 (13).
N-Bn-2-[(E)-prop-1-enyl]pyrrolidine (4a). (Isolated by the prepara-
tive-scale method 2) H NMR (400 MHz, CDCl3): δ 7.38-7.23 (m,
N-Boc-2-(but-2-enyl)pyrrolidine (Boc-10c/d). E/Z ) 76:24 mixture.
1H NMR (400 MHz, CDCl3) δ 5.56-5.31 (m, 2H), 3.79-3.71 (m,
1H), 3.40-3.20 (m, 2H), 2.45 (br s, 0.5H), 2.32 (br s, 0.5H), 2.05-
1.98 (m, 1H), 1.85-1.74 (m, 3H), 1.72-1.62 (m, 1H), 1.65 (d, 6.0
Hz, 3H), 1.46 (s, 9H); 13C NMR (125.7 MHz, CDCl3) δ 155.3, 127.9,
127.6, 126.8, 126.2, 79.1, 57.3, 46.9, 46.5, 37.9, 37.1, 30.3, 29.3, 28.8,
23.8, 23.1, 18.3, 13.0. Both isomers exhibit indistingishable mass
spectra; MS (rel abundance): [M - 55]+ 170.1 (17), 152.1 (11), 114.1
(88), 70.1 (100), 57.1 (83), 55.1 (12), 41.1 (37), 39.0 (13).
2-[3-Phenyl-(E)-prop-2-enyl]pyrrolidine (12c). 1H NMR (400
MHz, CDCl3) δ 7.36 (d, 8.0 Hz, 2H), 7.30 (t, 7.4 Hz, 2H), 7.21 (t, 7.0
Hz, 1H), 6.46 (d, 16.0 Hz, 1H), 6.24 (dt, 16.0 Hz, 7.2 Hz, 1H), 3.14
(quintet, 6.8 Hz, 1H), 3.06-2.98 (m, 1H), 2.88-2.82 (m, 1H), 2.37 (t,
6.6 Hz, 2H), 1.95-1.86 (m, 1H), 1.84-1.66 (m, 3H), 1.43-1.34 (m,
1H); 13C NMR (100.6 MHz, CDCl3) δ 137.6, 131.7, 128.5, 128.1, 127.1,
126.1, 59.0, 46.7, 40.1, 31.5, 25.6. MS (rel abundance): [M - 70]+
117.1 (5), 115.1 (9), 91.1 (5), 71.1 (5), 70.1 (100), 43.1 (5). HRMS-CI
(m/z): [MH+] calcd for C13H18N, 188.1439; found, 188.1437.
trans-2-Methyl-5-[(E)-prop-1-enyl]pyrrolidine (trans-14a). 1H NMR
(500 MHz, C6D6) δ 5.50 (d of quartet, 15.3 Hz, 5.5 Hz, 1H), 5.44 (dd,
15.3 Hz, 6.5 Hz, 1H), 3.64 (quartet, 6.5 Hz, 1H), 3.19 (sextet, 6.5 Hz,
1H), 1.89-1.82 (m, 1H), 1.80-1.74 (m, 1H), 1.58 (d, 5.5 Hz, 3H),
1.39 (d of quartet, 12.0 Hz, 8.5 Hz, 1H), 1.12 (d of quartet, 12.0 Hz,
8.5 Hz, 1H), 1.05 (m, 1 H), 1.00 (d, 6.5 Hz, 3H); 13C NMR (125.7
MHz, C6D6) δ 136.6, 124.0, 60.4, 53.6, 34.9, 34.0, 23.0, 18.2. MS (rel
abundance): M+ 125.1 (11), 124.1 (8), 110.1 (52), 93.1 (8), 84.1 (15),
82.1 (100), 68.0 (18), 67.1 (15), 55.1 (8), 53.0 (8), 44.0 (8), 42.0 (16),
41.0 (26), 39.0 (25). HRMS-EI (m/z): [M+] calcd for C8H15N, 125.1205;
found, 125.1191.
1
5H), 5.66 (d of quartet, 15.0 Hz, 6.4 Hz, 1H), 5.44 (ddd, 15.0 Hz, 8.2
Hz, 1.2 Hz, 1H), 4.07 (d, 12.8 Hz, 1H), 3.05 (d, 12.8 Hz, 1H), 2.95
(dt, 2.0 Hz, 8.2 Hz, 1H), 2.75 (quartet, 8.0 Hz, 1H), 2.09 (quartet, 8.8
Hz, 1H), 2.01-1.88 (m, 1H), 1.83-1.52 (m, 3H), 1.75 (d, 6.4 Hz, 3H);
13C NMR (100.6 MHz, CDCl3) δ 139.7, 133.8, 129.1, 128.2, 127.8,
126.7, 68.0, 58.4, 53.5, 31.9, 22.2, 18.2. MS (rel abundance): M+ 201.2
(17), 200.2 (13), 186.1 (20), 172.1 (12), 160.1 (29), 158.1 (13), 91.1
(100), 82.1 (16), 65.1 (22), 41.1 (16), 39.0 (15). HRMS-EI (m/z): [M+]
calcd for C14H19N, 201.1518; found, 201.1511.
2-[(E)-Prop-1-enyl]piperidine (6a).11b 1H NMR (500 MHz, C6D6)
δ 5.56-5.48 (m, 2H), 2.92-2.87 (m, 2H), 2.46 (dt, 11.5 Hz, 7.5 Hz,
1H), 1.68-1.64 (m, 1H), 1.60-1.54 (m, 1H), 1.57 (d, 4.5 Hz, 3H),
1.42-1.36 (m, 2H), 1.32-1.18 (m, 2H), 1.00 (s, 1H); 13C NMR (125.7
MHz, C6D6): δ 136.9, 124.4, 60.0, 47.7, 34.0, 26.9, 25.7, 18.3. MS
(rel abundance): M+ 125.1 (16), 124.1 (13), 110.1 (55), 97.1 (27),
96.1 (29), 84.1 (37), 82.1 (100), 83.1 (13), 69.0 (15), 68.1 (87), 67.1
(20), 56.1 (18), 55.0 (17), 54.0 (23), 53.0 (16), 44.0 (26), 43.0 (28),
42.0 (19), 41.0 (47), 40.0 (20), 39.0 (48). HRMS-EI (m/z): [M+] calcd
for C8H15N, 125.1205; found, 125.1204.
N-Boc-2-[(E)-prop-1-enyl]piperidine (Boc-6a). 1H NMR (500
MHz, CDCl3): δ 5.50 (d of quartet, 16.0 Hz, 6.0 Hz, 1H), 5.44 (dd,
16.0 Hz, 4.0 Hz, 1H), 4.73 (s, 1H), 3.92 (d, 13.0 Hz, 1H), 2.83 (dt, 2.5
Hz, 13.0 Hz, 1H), 1.70 (d, 5.5 Hz, 3H), 1.67-1.49 (m, 5H), 1.46 (s,
9H), 1.43-1.34 (m, 1H); 13C NMR (125.7 MHz, CDCl3) δ 155.6, 129.6,
126.6, 79.3, 52.1, 39.9, 29.7, 28.7, 25.9, 19.7, 18.1. MS (rel abun-
dance): M+ 225.1 (1), 170.1 (10), 169.1 (100), 154.1 (73), 152.1 (27),
141.1 (15), 128.1 (22), 124.1 (61), 110.1 (33), 97.1 (46), 96.1 (11),
84.1 (16), 82.1 (28), 68.1 (17), 67.1 (13), 57.1 (97), 56.1 (13), 55.1
(22), 43.1 (10), 41.1 (47), 39.1 (17). HRMS-EI (m/z): [M+] calcd for
C13H23NO2, 225.1729; found, 225.1729.
N-Boc-trans-2-methyl-5-propylpyrrolidine (trans-17). Trans:cis )
9:1 mixture, 1H NMR (500 MHz, CDCl3) δ 3.97-3.64 (m, 2H), 2.05-
1.76 (m, 3H), 1.61 (quartet, 6.0 Hz, 2H), 1.46 (s, 9H), 1.32-1.10 (m,
6H), 0.91 (t, 7.0 Hz, 3H); 13C NMR (125.7 MHz, CDCl3) δ 154.2,
154.1, 78.9, 57.8, 57.6, 54.1, 53.1, 53.0, 36.4, 35.3, 30.7, 29.9, 28.8,
27.6, 26.6, 20.6, 20.2, 20.1, 19.8, 19.6, 14.4, 14.3. Both isomers exhibit
indistingishable mass spectra; MS (rel abundance): M+ 227.2 (1), 184.1
(16), 154.1 (16), 128.1 (100), 84.1 (84), 69.1 (10), 57.1 (83), 56.1 (10),
55.1 (14), 43.1 (11), 42.1 (11), 41.1 (50), 39.0 (14). HRMS-EI (m/z):
[M+] calcd for C13H25NO2, 227.1886; found, 227.1888.
N-Cbz-2-[(E)-prop-1-enyl]piperidine (Cbz-6a). (Isolated by pre-
1
parative-scale method 1) H NMR (500 MHz, CDCl3) δ 7.43-7.28
(m, 5H), 5.61-5.45 (m, 2H), 5.17 and 5.13 (AB quartet, 12.5 Hz, 2H),
4.84 (s, 1H), 4.03 (d, 13.0 Hz, 1H), 2.92 (t, 12.0 Hz, 1H), 1.70 (d, 4.5
(21) Presumably, two possible conformers (pseudoequatorial or pseudoaxial
propenyl) exist which interconvert slowly on the NMR time scale; therefore,
some peaks appear as a pair.
9
15882 J. AM. CHEM. SOC. VOL. 125, NO. 51, 2003